title: [Fabry disease from the neurologist's point of view: is it a rare cause of strokes?].
authors.affiliation: Hospital General Universitario de Alicante, Alicante, Espana.
authors.forename: Silvia
authors.initials: S
authors.lastname: Marti-Martinez
authors.forename: Vicente
authors.initials: V
authors.lastname: Climent
authors.forename: Ana
authors.initials: A
authors.lastname: Pampliega-Perez
authors.forename: Carlos
authors.initials: C
authors.lastname: Martin-Estefania
authors.forename: Carlos
authors.initials: C
authors.lastname: Leiva-Santana
mesh_terms: D002545:Brain Ischemia / Q000209:etiology*; D056947:Enzyme Replacement Therapy; D000795:Fabry Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000652:urine; D005158:Facial Paralysis / Q000209:etiology; D005915:Globosides / Q000652:urine; D006801:Humans; D006987:Hypesthesia / Q000209:etiology; D007438:Introns / Q000235:genetics; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009128:Muscle Spasticity / Q000209:etiology; D059906:Neuroimaging; D012008:Recurrence; D017384:Sequence Deletion; D059409:Stroke, Lacunar / Q000209:etiology*; D014281:Trihexosylceramides / Q000652:urine; D000519:alpha-Galactosidase / Q000235:genetics / Q000627:therapeutic use
chemical_list: D005915:Globosides; D014281:Trihexosylceramides; C514780:globotrihexosylceramide; D000519:alpha-Galactosidase